HMMR and prostate carcinoma: Although RHAMM peptide mimetics have not yet been extensively tested for their ability to reduce tumorigenesis, they have been reported to reduce melanoma tumorigenesis [133] and breast and prostate cancer cell invasion [84,134] and proliferation in vitro and in vivo [135].